Literature DB >> 36073709

Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration.

Dan J Stein1, Steven J Shoptaw2, Daniel V Vigo3, Crick Lund4, Pim Cuijpers5, Jason Bantjes6, Norman Sartorius7, Mario Maj8.   

Abstract

Psychiatry has always been characterized by a range of different models of and approaches to mental disorder, which have sometimes brought progress in clinical practice, but have often also been accompanied by critique from within and without the field. Psychiatric nosology has been a particular focus of debate in recent decades; successive editions of the DSM and ICD have strongly influenced both psychiatric practice and research, but have also led to assertions that psychiatry is in crisis, and to advocacy for entirely new paradigms for diagnosis and assessment. When thinking about etiology, many researchers currently refer to a biopsychosocial model, but this approach has received significant critique, being considered by some observers overly eclectic and vague. Despite the development of a range of evidence-based pharmacotherapies and psychotherapies, current evidence points to both a treatment gap and a research-practice gap in mental health. In this paper, after considering current clinical practice, we discuss some proposed novel perspectives that have recently achieved particular prominence and may significantly impact psychiatric practice and research in the future: clinical neuroscience and personalized pharmacotherapy; novel statistical approaches to psychiatric nosology, assessment and research; deinstitutionalization and community mental health care; the scale-up of evidence-based psychotherapy; digital phenotyping and digital therapies; and global mental health and task-sharing approaches. We consider the extent to which proposed transitions from current practices to novel approaches reflect hype or hope. Our review indicates that each of the novel perspectives contributes important insights that allow hope for the future, but also that each provides only a partial view, and that any promise of a paradigm shift for the field is not well grounded. We conclude that there have been crucial advances in psychiatric diagnosis and treatment in recent decades; that, despite this important progress, there is considerable need for further improvements in assessment and intervention; and that such improvements will likely not be achieved by any specific paradigm shifts in psychiatric practice and research, but rather by incremental progress and iterative integration.
© 2022 World Psychiatric Association.

Entities:  

Keywords:  Hierarchical Tax­onomy of Psychopathology; Mental disorder; Research Domain Criteria; clinical neuroscience; community mental health care; deinstitutionalization; digital phenotyping; digital therapies; evidence-based psychotherapy; global mental health; incremental integration; paradigm shifts; personalized psychiatry; psychiatric nosology; task-sharing approaches

Year:  2022        PMID: 36073709      PMCID: PMC9453916          DOI: 10.1002/wps.20998

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   79.683


  223 in total

1.  Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders.

Authors:  Gavin Andrews; Cathy Issakidis; Kristy Sanderson; Justine Corry; Helen Lapsley
Journal:  Br J Psychiatry       Date:  2004-06       Impact factor: 9.319

Review 2.  All for One and One for All: Mental Disorders in One Dimension.

Authors:  Avshalom Caspi; Terrie E Moffitt
Journal:  Am J Psychiatry       Date:  2018-04-06       Impact factor: 18.112

3.  Report of the WPA task force on brain drain.

Authors:  Oye Gureje; Sheila Hollins; Michel Botbol; Afzal Javed; Migue Jorge; Violet Okech; Michelle Riba; Jitendra Trivedi; Norman Sartorius; Rachel Jenkins
Journal:  World Psychiatry       Date:  2009-06       Impact factor: 49.548

Review 4.  Clinical review of user engagement with mental health smartphone apps: evidence, theory and improvements.

Authors:  John Torous; Jennifer Nicholas; Mark E Larsen; Joseph Firth; Helen Christensen
Journal:  Evid Based Ment Health       Date:  2018-06-05

Review 5.  The Lancet Commission on global mental health and sustainable development.

Authors:  Vikram Patel; Shekhar Saxena; Crick Lund; Graham Thornicroft; Florence Baingana; Paul Bolton; Dan Chisholm; Pamela Y Collins; Janice L Cooper; Julian Eaton; Helen Herrman; Mohammad M Herzallah; Yueqin Huang; Mark J D Jordans; Arthur Kleinman; Maria Elena Medina-Mora; Ellen Morgan; Unaiza Niaz; Olayinka Omigbodun; Martin Prince; Atif Rahman; Benedetto Saraceno; Bidyut K Sarkar; Mary De Silva; Ilina Singh; Dan J Stein; Charlene Sunkel; JÜrgen UnÜtzer
Journal:  Lancet       Date:  2018-10-09       Impact factor: 79.321

6.  An organization- and category-level comparison of diagnostic requirements for mental disorders in ICD-11 and DSM-5.

Authors:  Michael B First; Wolfgang Gaebel; Mario Maj; Dan J Stein; Cary S Kogan; John B Saunders; Vladimir B Poznyak; Oye Gureje; Roberto Lewis-Fernández; Andreas Maercker; Chris R Brewin; Marylene Cloitre; Angelica Claudino; Kathleen M Pike; Gillian Baird; David Skuse; Richard B Krueger; Peer Briken; Jeffrey D Burke; John E Lochman; Spencer C Evans; Douglas W Woods; Geoffrey M Reed
Journal:  World Psychiatry       Date:  2021-02       Impact factor: 49.548

7.  The subjective in medicine.

Authors:  L Eisenberg
Journal:  Perspect Biol Med       Date:  1983       Impact factor: 1.416

Review 8.  The balanced care model for global mental health.

Authors:  G Thornicroft; M Tansella
Journal:  Psychol Med       Date:  2012-07-11       Impact factor: 7.723

9.  The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality.

Authors:  John Torous; Sandra Bucci; Imogen H Bell; Lars V Kessing; Maria Faurholt-Jepsen; Pauline Whelan; Andre F Carvalho; Matcheri Keshavan; Jake Linardon; Joseph Firth
Journal:  World Psychiatry       Date:  2021-10       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.